Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 44,950 shares at $73.94 ($2.6M) on 2022-11-14, disclosed to the SEC on 2022-11-14.
Seasonal sale ($2.6M) by Chairman & CEO — this insider has traded EW in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $73.94 | 15,575 | $1.2M | 43.9% |
| 3 | $73.94 | 15,575 | $1.2M | 43.9% |
| 4 | $74.86 | 4,100 | $307K | 11.7% |
| 5 | $75.47 | 200 | $15K | 0.6% |
| Total | $58.40 avg | 44,950 |
| $2.6M |
| 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |